Charles Schwab
EVLO

Charles Schwab’s Evelo Biosciences, Inc. Common Stock EVLO Stock Holding History

Charles Schwab’s Portfolio EVLO Stock Details EVLO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-1,567
Closed -$50.5K – 3605
2022
Q4 		$50.5K Hold
1,567
– – ﹤0.01% 3357
2022
Q3 		$66K Sell
1,567
-4,396
-74% -$201K ﹤0.01% 3272
2022
Q2 		$252K Sell
5,963
-4,287
-42% -$199K ﹤0.01% 3214
2022
Q1 		$695K Buy
10,250
+167
+2% +$13.9K ﹤0.01% 2991
2021
Q4 		$1.23M Buy
10,083
+349
+4% +$58.9K ﹤0.01% 2837
2021
Q3 		$1.37M Buy
9,734
+125
+1% +$24.8K ﹤0.01% 2779
2021
Q2 		$2.64M Buy
9,609
+1,089
+13% +$275K ﹤0.01% 2620
2021
Q1 		$1.82M Buy
8,520
+1,892
+29% +$523K ﹤0.01% 2690
2020
Q4 		$1.6M Sell
6,628
-586
-8% -$72.5K ﹤0.01% 2654
2020
Q3 		$761K Buy
7,214
+3,544
+97% +$323K ﹤0.01% 2746
2020
Q2 		$360K Buy
3,670
+258
+8% +$22.6K ﹤0.01% 2964
2020
Q1 		$257K Buy
3,412
+51
+2% +$4.86K ﹤0.01% 2938
2019
Q4 		$273K Sell
3,361
-442
-12% -$49.5K ﹤0.01% 2995
2019
Q3 		$465K Buy
3,803
+1,598
+72% +$220K ﹤0.01% 2829
2019
Q2 		$397K Buy
2,205
+154
+8% +$24.9K ﹤0.01% 2917
2019
Q1 		$329K Buy
2,051
+24
+1% +$4.75K ﹤0.01% 2915
2018
Q4 		$528K Buy
2,027
+829
+69% +$167K ﹤0.01% 2745
2018
Q3 		$292K Buy
1,198
+69
+6% +$18.1K ﹤0.01% 3011
2018
Q2 		$267K Buy
+1,129
New +$329K ﹤0.01% 3011

Other funds holding EVLO

FP
Flagship Pioneering Cambridge, Massachusetts $1.54B AUM 86.39% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
SOMRS
State of Michigan Retirement System Lansing, Michigan $22.6B AUM 40.24% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
HP
Harbourvest Partners Boston, Massachusetts $170M AUM 34.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AI
Alphabet Inc Mountain View, California $99.1B AUM 124.46% 1-Year Est. Return
CH
CVI Holdings Wilmington, Delaware $116M AUM 5.68% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Charles Schwab's EVLO Position: Q1 2023 in Review

Charles Schwab sold out of Evelo Biosciences, Inc. Common Stock (EVLO) in Q1 2023, closing a stake of 1,567 shares — an estimated $50.5K sold.

Charles Schwab first reported a position in EVLO in Q2 2018 and held it in 19 quarters. The position peaked at $2.64M in Q2 2021. 39 funds tracked by Wall St. Rank hold EVLO as of Q1 2023.

  • Charles Schwab reported no remaining Evelo Biosciences, Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
  • Charles Schwab sold 1,567 Evelo Biosciences, Inc. Common Stock shares in Q1 2023, an estimated $50.5K.
  • Charles Schwab first reported a position in Evelo Biosciences, Inc. Common Stock in Q2 2018 and held it in 19 quarters.
  • Charles Schwab's Evelo Biosciences, Inc. Common Stock position peaked at $2.64M in Q2 2021.
  • 39 funds tracked by Wall St. Rank held Evelo Biosciences, Inc. Common Stock as of Q1 2023.

Based on Charles Schwab's 13F filing for Q1 2023, filed 12 May 2023.